ARMP
Armata Pharmaceuticals Inc
NYSE MKT: ARMP · HEALTHCARE · BIOTECHNOLOGY
$9.87
+3.35% today
Updated 2026-04-30
Market cap
$366.22M
P/E ratio
—
P/S ratio
74.68x
EPS (TTM)
$-4.80
Dividend yield
—
52W range
$1 – $15
Volume
0.1M
Armata Pharmaceuticals Inc (ARMP) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |